Savarese, Gianluigi
 Distribuzione geografica
Continente #
AS - Asia 1.103
NA - Nord America 765
EU - Europa 423
SA - Sud America 253
AF - Africa 26
Totale 2.570
Nazione #
US - Stati Uniti d'America 724
SG - Singapore 423
CN - Cina 243
BR - Brasile 216
IT - Italia 163
HK - Hong Kong 158
BD - Bangladesh 78
VN - Vietnam 73
DE - Germania 47
FR - Francia 41
RU - Federazione Russa 37
TR - Turchia 34
GB - Regno Unito 29
FI - Finlandia 27
CA - Canada 24
IN - India 21
IQ - Iraq 15
NL - Olanda 15
ES - Italia 12
SA - Arabia Saudita 12
AR - Argentina 11
AT - Austria 11
UA - Ucraina 11
PK - Pakistan 8
CO - Colombia 7
MX - Messico 7
PL - Polonia 7
MA - Marocco 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
JP - Giappone 5
VE - Venezuela 5
KE - Kenya 4
LT - Lituania 4
SE - Svezia 4
UZ - Uzbekistan 4
CL - Cile 3
CR - Costa Rica 3
EC - Ecuador 3
ID - Indonesia 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
PH - Filippine 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
IR - Iran 2
JM - Giamaica 2
MD - Moldavia 2
MG - Madagascar 2
PS - Palestinian Territory 2
PY - Paraguay 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TC - Turks e Caicos 1
TT - Trinidad e Tobago 1
Totale 2.570
Città #
Singapore 214
Hong Kong 157
San Jose 103
Ashburn 98
Beijing 71
The Dalles 68
New York 45
Los Angeles 35
Dallas 34
Lauterbourg 30
Istanbul 28
Milan 27
Ho Chi Minh City 25
São Paulo 25
Santa Clara 22
Moscow 17
Romola 17
Buffalo 16
Hanoi 16
Munich 15
Lappeenranta 14
Redondo Beach 13
Rome 12
San Francisco 12
Frankfurt am Main 11
Shanghai 11
Chennai 10
Chicago 10
Nuremberg 10
Turin 10
Orem 9
Montreal 8
Atlanta 7
Da Nang 7
Guangzhou 7
Naples 7
Rio de Janeiro 7
Amsterdam 6
Baghdad 6
Belo Horizonte 6
Charlotte 6
Council Bluffs 6
Denver 6
Helsinki 6
Turku 6
Warsaw 6
Bari 5
Brasília 5
Brooklyn 5
Hangzhou 5
Toronto 5
Boston 4
Brescia 4
Dhaka 4
Erbil 4
Jeddah 4
London 4
Manchester 4
Nairobi 4
San Rafael 4
Stockholm 4
São Bernardo do Campo 4
Tokyo 4
Vienna 4
West Jordan 4
Airola 3
Basra 3
Boardman 3
Cagliari 3
Caracas 3
Contagem 3
Haiphong 3
Itajaí 3
Johannesburg 3
Kyiv 3
Lahore 3
Livorno 3
Manaus 3
Medellín 3
Medina 3
Montevideo 3
Phoenix 3
Piracicaba 3
Pittsburgh 3
Porto Alegre 3
Potsdam 3
Salvador 3
San José 3
Serra 3
Sorocaba 3
Tashkent 3
Thái Bình 3
Zhengzhou 3
A Coruña 2
Angra dos Reis 2
Ankara 2
Araruama 2
Bagnoli del Trigno 2
Bernareggio 2
Bogotá 2
Totale 1.461
Nome #
2024 update in heart failure 167
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC 114
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC 102
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 86
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry 86
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 85
Insights into the European heart failure epidemiology 82
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC 79
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 79
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 76
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry 75
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC 74
Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis 74
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 73
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry 72
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) 72
Comprehensive Characterization of Non-Cardiac Comorbidities in Acute Heart Failure- an analysis of ESC-HFA EORP Heart Failure Long-Term Registry 71
Efficacy of SGLT2-inhibitors across different definitions of heart failure with preserved ejection fraction 70
Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: an analysis from the Swedish Heart Failure Registry 69
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 68
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension 67
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 66
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC 62
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 60
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) 59
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 59
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 58
Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis 57
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure 56
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry 56
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: insight from the ESC-HFA EORP Heart Failure Long-Term Registry 54
Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure 51
Rationale and Design of the ESC Heart Failure III Registry - Implementation and Discovery 49
Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions 48
Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC 46
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice 44
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 41
Totale 2.607
Categoria #
all - tutte 13.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 0 0 0 0 0 0 5
2023/2024195 3 8 4 7 16 2 11 8 46 10 38 42
2024/2025590 9 2 25 70 49 37 79 15 52 40 114 98
2025/20261.807 215 197 117 203 139 98 207 141 173 121 123 73
2026/202710 10 0 0 0 0 0 0 0 0 0 0 0
Totale 2.607